Transcript Slide 1
HREB 101
… a few other things you may want to
know about ethics applications…
CHARMAINE KABATOFF, SENIOR REB
COORDINATOR HREB PANEL B
FEBRUARY 9, 2012
By the end of the presentation you should be…
Familiar with HREB and the new REB structure at
the U of A.
Understand the application process, including a
brief introduction to HERO.
Understand common application pitfalls.
Understand where to go for HELP.
Health Research Ethics Board (HREB)
administers and reviews all research where the
researcher will access health information (as
defined in the Health Information Act of
Alberta) OR conduct the research at Alberta
Health Services or Covenant Health facilities.
HREB – two review panels
Biomedical Panel
This REB deals with health research applications that involve invasive
interventions and invasive measures, regardless of how significant a
part the intervention or measure has in the overall project, for example:
- administration of drugs, vaccines, natural health products.
-
use of a device in a research study.
surgical procedures.
collection of blood or other specimens.
genetic research.
any research funded by a US federal funding source (i.e., NIH)
HREB - two review panels
Health Panel
This REB reviews applications for health research that primarily
involves non-invasive interventions (behavioural, educational,
psychological and training) or concerns privacy, confidentiality and
survey methods. For example:
interviews
chart reviews
surveys
questionnaires
educational strategies
observational or descriptive research
HREB Review
Each panel meets monthly; schedule posted on the website
(www.hreb.ualberta.ca)
Two types of Review Streams – Full Board or Delegated.
Type of review is related to the level of risk and whether the
study is classified as above or below “minimal risk”
Full board (deadline 2 weeks prior to meeting), delegated review
NO deadlines.
Online submission via HERO.
Researchers should expect the following timelines from
submission to final approval:
Delegated Review – Approximately 1 month
Full Board Review – Approximately 6 weeks
HREB Work Flow
PI – Submit Ethics Application
Pre-REB/Departmental Approvals
Changes Requested
REB Administrator
Full Board Review
Delegated Review
Standards and Policy
Tri-Council Policy Statement2: Ethical Conduct for
Research Involving Humans - current national
standard for all research involving human subjects.
University of Alberta GFC policy – Protection of
Human Research Participants – GFC Section 66
Guiding Ethical Principles – TCPS2
Respect for Persons
Concern for Welfare
Justice
Your Application:
what you need to consider
Scientific validity
Risk/benefit ratio
Sample size (can you find the number of subjects required)
Can the project be completed in the allotted time
Access to patients – can you?
How are you recruiting participants?
Who is obtaining consent? How?
Risk/Benefit Ratio
One of the more important and challenging aspects of
review
no greater than what they would experience under similar circumstances in
their everyday life then the study may be of minimal risk.
greater than they would encounter in their everyday lives, the protocol is
subject to a higher degree of scrutiny and must make more provisions for the
potential participants
The REB must consider whether the potential benefits of a study justify
the exposure of people to the potential risks
Privacy and Confidentiality
Access to health information is considered within an ethics
review of a research proposal
Section 50 and 55 of Health Information Act guide research
Which hat are you wearing: researcher or custodian, will
determine whether you have access to potential
participants records
If you do not have access the “custodian”/treating
clinician, must obtain WRITTEN consent for disclosure
to release participant’s name
Privacy and Confidentiality
Access to records/data
Participants identified as a “code”
Who will have the link?
Security of records (during the study)
Who will have access?
Paper records, kept in a locked office
Electronic Records – password protected, encrypted
Storage of Data
5 years per University policy
25 years if conducted under Division 5
Informed Consent
According to the TCPS Tri-Council Policy
Statement 2 (article 2) research may only
begin if prospective participants, or
authorized third parties, have been given the
opportunity to give free and informed consent
to participate.
There are, however, circumstances under which the
informed consent procedure can be altered or
waived.
Informed Consent…written or …?
The consent process may be altered (waived, delayed, presented in a
different format) with REB approval under the following conditions:
The research involves no more than minimal risk
The waiver or alteration is unlikely to have a negative effect on the
rights and welfare of the participants
The research could not practicably be carried out without the waiver
or alteration
Whenever possible and appropriate additional pertinent
information will be provided after participation
The waived or altered consent does not involve a therapeutic
intervention.
Informed Consent – some examples
retrospective chart reviews – can request a WAIVER
secondary data analysis (no direct contact with
subjects) - depends on how it was collected in the first
place
completion and return of surveys and questionnaires
implies consent to use the data, and does not require
signed consent although subjects in such research
should be provided with an information letter
Observation of people in a public environment
Assent
For research involving participants not competent to consent on their own
an authorized third party may be able to consent on their behalf (i.e.
children, people with diminished capacity for judgement and self direction,
people in emergency situations).
Once consent has been obtained from an authorized 3rd party, the
individual must still be asked for their agreement (assent). TCPS Article
2.7. Those who may be capable of assent or dissent include:
children, whose capacity for judgement and self-direction is maturing
adults whose competence has become diminished, (e.g. people with early
Alzheimer's disease)
those whose competence remains only partially developed (e.g. adults and
children with permanent cognitive impairment)
Quality Assurance TCPS and GFC 66
Quality assurance studies, performance reviews of an
organization, or its employees or students within the mandate of
the organization, or testing within normal educational
requirements, are not subject to REB review unless they contain
an element of research in addition to assessment.
Researchers should seek the advice of their REBs whenever there
is any ambiguity or doubt about the applicability of the UA
Standards to a particular project.
Approval!! Now what?
Approval is normally granted for one year.
Renewal reminders are sent via UA e-mail directly to
the PI and named members of the study team
starting at 45 days prior to expiration.
All changes to the research project must be
submitted to and approved by the REB before
implementation.
Submission of a closing report upon completion of
study.
HERO
(Human Ethics Research Online)
Complete application management system, from
initial submission to study closure and beyond.
Permits collaboration during application
development.
Monitor approval status online.
Incorporate material from various sources.
Save, copy and link applications.
Access to HERO
Active relationship in PeopleSoft HR system
(employee, student, guest)
CCID and password – used for authentication
purposes.
All UA employees have a CCID and password. If
unsure, contact AICT.
Guests may apply for a CCID through their unit of
affiliation (dept or faculty)
HERO role is used to define permissions.
Getting Started
Faculty Members & Clinicians
HERO investigator role auto-generated.
Proceed to logon
Study Coordinators, students & outside applicants
Self register first.
Proceed to logon
First Time Logon
Researcher must identify department for approval routing.
Researcher may add authorized study coordinators at this
time.
Researcher Profile
First time logon will prompt you to complete your
profile.
Basic information extracted from PeopleSoft
Name study coordinators in Authorization List in
Researcher Profile.
Study Access
Who can access a study?
During preparation – the PI, study coordinator (SC) and all coinvestigators (Co-I) can read and edit the application. ONLY
the PI can submit the study for initial review.
Post submission, the PI, SC and Co-Is can respond to requests
for changes and submit renewals/amendments.
To give view only access to someone you can add them to the
Guest List for the study, all HERO users are available in the
list.
To allow someone to receive all HERO notifications about the
study, add them to the Study Email List.
Email Notifications
Initial submission
Change requests from reviewers
REB decision/approval
Renewal reminders – except when an amendment is
pending.
Notifications automatically go to the PI and SC. CoI’s must be added to the email list to receive notices.
HERO only sends to @ualberta.ca email addresses.
HERO Website
https://HERO.ualberta.ca/HERO
link from UofA and Research Ethics Office
(www.reo.ualberta.ca) websites
• Mac users must use Firefox or Internet Explorer as
web browser – Safari is not compatible with HERO.
• The first time you use HERO, disengage your pop-up
blocker and make HERO a trusted site.
Important Links
www.hreb.ualberta.ca (for up to date information
about HREB and HERO applications)
http://pre.ethics.gc.ca/eng/policy-politique/tcpseptc/readtcps-lireeptc (for Tri-Council Policy
Statement: Ethical Conduct for Research
Involving Humans); includes link to tutorial
http://www.uofaweb.ualberta.ca/gfcpolicymanua
l (see section 66 for up-to-date University of
Alberta policies on research involving humans)
Points to Remember (tips for a successful application)
Answering only the red asterisk questions does not
constitute a complete application.
The more detail the better!
N/A should be used sparingly.
Ensure all relevant documentation is attached.
If the study is in your inbox – its waiting on an
action from you!
Be able to provide the Pro number when contacting
your REB Administrator.
WHEN IN DOUBT….
check it out….
Where to find us
Health Research Ethics Board
308 CAMPUS TOWER
UNIVERSITY OF ALBERTA
CHARMAINE KABATOFF (HEALTH PANEL)
492-0302
PATRICIA LO (BIOMEDICAL PANEL) 4929724
ALICE FRITCH HERO HELPDESK 492-0839
REO OFFICE 492-0459
WEBSITE:
WWW.HREB.UALBERTA.CA